Basic cancer research is essential for the success of personalised medicine

摘要: The last decade has witnessed significant progress in cancer understanding and therapy: we can now identify the genetic drivers of individual tumours, tailor drugs able to specifically intercept driver mutations. While all agree that personalised medicine is a clear outcome resources dedicated research over 50 years, some critics question necessity for continuous investments sub-fields other than clinical drug development. Herein, scientists from European Association Cancer Research (EACR) argue new ways diagnose treat present important hitherto unaddressed challenges fundamental cancer. Allocating needed basic studies will likely fuel next wave achievements long way conquer